Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1855 per EA under NDC 00378632577. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Sep 21, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB

valsartan and hydrochlorothiazide
$0.1855per EA

Strength

25; 320 mg/1; mg/1

NDC

00378632577

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078020

FDA Approved

9/21/2012

TE Code

AB

On Market Since

9/21/2012

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1855 per EA
All-time high$0.6097 (Nov 11, 2020)
All-time low$0.1855 (Oct 21, 2026)
52-week high$0.2220
52-week low$0.1855
Median price$0.3047
Average price$0.3212
Largest weekly change+33.7% (Oct 21, 2020)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.2%

3M

-11.8%

6M

-15.8%

1Y

-10.6%

3Y

-26.9%

5Y

-56.8%

All

-57.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.1855 per EA (NDC 00378632577), effective Nov 11, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has declined 57.6%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

Since Nov 28, 2013, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has ranged from a low of $0.1855 (Oct 21, 2026) to a high of $0.6097 (Nov 11, 2020), with a median of $0.3047 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB (NDC 00378632577) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.